Aspirin Found to Decrease Mortality in Breast Cancer Patients

A recent study reported in Medical News Today and published in the Journal of Clinical Oncology suggests that women who take aspirin at the conclusion of chemotherapy are less likely to die from breast cancer.

The study involved 4,164 female registered nurses who were diagnoses with breast cancer between 1976 and 2002. Because aspirin is contraindicated during chemotherapy, those patients who took aspirin generally began taking the drug a year after their breast cancer diagnosis.

The result of the study suggests a positive correlation between taking aspiring and decreased mortality rates. Women who took aspirin at least two days a week reduced their mortality risk by 64% to 71%.

Tags: aspirin, breast cancer, Medical Research, Nash & Associates